Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (391-400 of 567) with videos related to

Pageof 57
Sort By:
Journal of General Internal Medicine|July 1, 1996
Race, resource use, and survival in seriously ill hospitalized adults. The SUPPORT InvestigatorsR S Phillips, M B Hamel, J M Teno, et al.
Journal of the American College of Cardiology|February 1, 1997
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesB E Tardiff, R M Califf, D Morris, et al.
Lancet (London, England)|January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trialD R Holmes, R M Califf, F Van de Werf, et al.
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
American Heart Journal|January 8, 1999
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total OcclusionN S Kleiman, C B Granger, H D White, et al.
European Heart Journal|July 22, 1999
Minimal myocardial damage during coronary intervention is associated with impaired outcomeM L Simoons, M van den Brand, M Lincoff, et al.
European Heart Journal|October 29, 2000
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb InvestigatorsD K McGuire, H Emanuelsson, C B Granger, et al.
The New England Journal of Medicine|May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarctionD B Mark, M A Hlatky, R M Califf, et al.
Journal of the American College of Cardiology|October 1, 1990
Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplastyC W Abbottsmith, E J Topol, B S George, et al.
Thrombosis and Haemostasis|March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarctionD C Sane, D C Stump, E J Topol, et al.
Pageof 57

Showing results (391-400 of 567) with videos related to

Sort By:
Pageof 57
Journal of General Internal Medicine|July 1, 1996
Race, resource use, and survival in seriously ill hospitalized adults. The SUPPORT InvestigatorsR S Phillips, M B Hamel, J M Teno, et al.
Journal of the American College of Cardiology|February 1, 1997
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesB E Tardiff, R M Califf, D Morris, et al.
Lancet (London, England)|January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trialD R Holmes, R M Califf, F Van de Werf, et al.
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
American Heart Journal|January 8, 1999
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total OcclusionN S Kleiman, C B Granger, H D White, et al.
European Heart Journal|July 22, 1999
Minimal myocardial damage during coronary intervention is associated with impaired outcomeM L Simoons, M van den Brand, M Lincoff, et al.
European Heart Journal|October 29, 2000
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb InvestigatorsD K McGuire, H Emanuelsson, C B Granger, et al.
The New England Journal of Medicine|May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarctionD B Mark, M A Hlatky, R M Califf, et al.
Journal of the American College of Cardiology|October 1, 1990
Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplastyC W Abbottsmith, E J Topol, B S George, et al.
Thrombosis and Haemostasis|March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarctionD C Sane, D C Stump, E J Topol, et al.
Pageof 57